Drugs / GSK1827771
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00539760 | Sep 2007 → Apr 2008 | rheumatoid arthritis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK1827771 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00539760 ↗ |
| Route | Subcutaneous | “GSK1827771 will be administered using injection via subcutaneous (SC) route.” NCT00539760 ↗ |